Lusiane M. Bendhack
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Ang II-induced contraction is impaired in the aortas of renovascular hypertensive animal model.
Journal: Vascular biology (Bristol, England)
Published: December 20, 2023
Influence of nitro ruthenium isomerization on photochemically induced nitric oxide release: Vasorelaxant activities.
Journal: Journal of inorganic biochemistry
Published: August 25, 2022
RuBPY decreases intracellular calcium by decreasing influx and increasing storage.
Journal: Clinical and experimental pharmacology & physiology
Published: October 07, 2021
Glypican 1 and syndecan 1 differently regulate noradrenergic hypertension development: Focus on IP3R and calcium.
Journal: Pharmacological research
Published: April 06, 2021
Thromboxane-prostanoid receptor activation blocks ATP-sensitive potassium channels in rat aortas.
Journal: Clinical and experimental pharmacology & physiology
Published: February 10, 2021
Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats.
Journal: Frontiers in physiology
Published: January 20, 2021
C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
Journal: Life sciences
Published: November 30, 2020
Central Administration of Angiotensin-(1-7) Improves Vasopressin Impairment and Hypotensive Response in Experimental Endotoxemia.
Journal: Cells
Published: November 24, 2020
The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases.
Journal: Frontiers in physiology
Published: October 23, 2020
Testosterone increases bradykinin-induced relaxation in the coronary bed of hypertensive rats.
Journal: Journal of molecular endocrinology
Published: August 05, 2020
Reversion of cardiovascular remodelling in renovascular hypertensive 2K-1C rats by renin-angiotensin system inhibitors.
Journal: Clinical and experimental pharmacology & physiology
Published: March 31, 2020
Nitric Oxide Donors as Potential Drugs for the Treatment of Vascular Diseases Due to Endothelium Dysfunction.
Journal: Current pharmaceutical design
Published: January 07, 2020
Last Updated: 09/26/2026